Industry Research Reports

Home > Reports > Pharma & Healthcare > Nifedipine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Nifedipine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 132 Pages

Report ld: 2333662

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. 
The global market for Nifedipine was estimated to be worth US$ 1010.8 million in 2023 and is forecast to a readjusted size of US$ 1726.7 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030

Nifedipine Market Size

M= millions and B=billions

The nifedipine market based on geography can be further segmented into North America, Europe, Asia Pacific, South America, and Rest of the World. North America will account for the largest share in 2022. The growth of this segment is due to factors such as widespread obesity among the American public leading to increased ailments such as heart disease, angina, hypertension, etc. In 2021, the United States leads every other country on earth in obesity rates. Approximately 36.20% of adults in the United States face overweight issues, which leads the calcium channel blocker drugs market.

However, Asia Pacific is expected to be the fastest growing segment. This growth is due to the increasing elderly population, especially in countries like India and China, the rise in chronic diseases, and the continuous improvement of medical infrastructure as governments allocate countless funds for development.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Nifedipine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nifedipine by region & country, by Type, and by Application.

The Nifedipine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nifedipine.

Market Segmentation

Report Metric
Details
Report Title
Nifedipine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1726.7 million
CAGR(2024-2030)
7.9%
Market Size Available for Years
2019-2030
Global Nifedipine Companies Covered
Bayer, Actavis, Teva, Pfizer, Shyndec, Honglin Pharmaceutical, Huanghai, Yabao, Lifeon Pharmaceutical, EASEHEAL Pharmaceutical, ApicHope, Simcere
Global Nifedipine Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nifedipine Market, Segment by Type
Nifedipine Controlled Release Tablets

Nifedipine Extended Action Tablets
Global Nifedipine Market, Segment by Application
Hypertension

Heart Disease

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nifedipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nifedipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nifedipine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Nifedipine Product Introduction
    1.2 Global Nifedipine Market Size Forecast
        1.2.1 Global Nifedipine Sales Value (2019-2030)
        1.2.2 Global Nifedipine Sales Volume (2019-2030)
        1.2.3 Global Nifedipine Sales Price (2019-2030)
    1.3 Nifedipine Market Trends & Drivers
        1.3.1 Nifedipine Industry Trends
        1.3.2 Nifedipine Market Drivers & Opportunity
        1.3.3 Nifedipine Market Challenges
        1.3.4 Nifedipine Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Nifedipine Players Revenue Ranking (2023)
    2.2 Global Nifedipine Revenue by Company (2019-2024)
    2.3 Global Nifedipine Players Sales Volume Ranking (2023)
    2.4 Global Nifedipine Sales Volume by Company Players (2019-2024)
    2.5 Global Nifedipine Average Price by Company (2019-2024)
    2.6 Key Manufacturers Nifedipine Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Nifedipine Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Nifedipine
    2.9 Nifedipine Market Competitive Analysis
        2.9.1 Nifedipine Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Nifedipine Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Nifedipine Controlled Release Tablets
        3.1.2 Nifedipine Extended Action Tablets
    3.2 Global Nifedipine Sales Value by Type
        3.2.1 Global Nifedipine Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Nifedipine Sales Value, by Type (2019-2030)
        3.2.3 Global Nifedipine Sales Value, by Type (%) (2019-2030)
    3.3 Global Nifedipine Sales Volume by Type
        3.3.1 Global Nifedipine Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Nifedipine Sales Volume, by Type (2019-2030)
        3.3.3 Global Nifedipine Sales Volume, by Type (%) (2019-2030)
    3.4 Global Nifedipine Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hypertension
        4.1.2 Heart Disease
        4.1.3 Other
    4.2 Global Nifedipine Sales Value by Application
        4.2.1 Global Nifedipine Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Nifedipine Sales Value, by Application (2019-2030)
        4.2.3 Global Nifedipine Sales Value, by Application (%) (2019-2030)
    4.3 Global Nifedipine Sales Volume by Application
        4.3.1 Global Nifedipine Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Nifedipine Sales Volume, by Application (2019-2030)
        4.3.3 Global Nifedipine Sales Volume, by Application (%) (2019-2030)
    4.4 Global Nifedipine Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Nifedipine Sales Value by Region
        5.1.1 Global Nifedipine Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Nifedipine Sales Value by Region (2019-2024)
        5.1.3 Global Nifedipine Sales Value by Region (2025-2030)
        5.1.4 Global Nifedipine Sales Value by Region (%), (2019-2030)
    5.2 Global Nifedipine Sales Volume by Region
        5.2.1 Global Nifedipine Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Nifedipine Sales Volume by Region (2019-2024)
        5.2.3 Global Nifedipine Sales Volume by Region (2025-2030)
        5.2.4 Global Nifedipine Sales Volume by Region (%), (2019-2030)
    5.3 Global Nifedipine Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Nifedipine Sales Value, 2019-2030
        5.4.2 North America Nifedipine Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Nifedipine Sales Value, 2019-2030
        5.5.2 Europe Nifedipine Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Nifedipine Sales Value, 2019-2030
        5.6.2 Asia Pacific Nifedipine Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Nifedipine Sales Value, 2019-2030
        5.7.2 South America Nifedipine Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Nifedipine Sales Value, 2019-2030
        5.8.2 Middle East & Africa Nifedipine Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Nifedipine Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Nifedipine Sales Value
        6.2.1 Key Countries/Regions Nifedipine Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Nifedipine Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Nifedipine Sales Value, 2019-2030
        6.3.2 United States Nifedipine Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Nifedipine Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Nifedipine Sales Value, 2019-2030
        6.4.2 Europe Nifedipine Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Nifedipine Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Nifedipine Sales Value, 2019-2030
        6.5.2 China Nifedipine Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Nifedipine Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Nifedipine Sales Value, 2019-2030
        6.6.2 Japan Nifedipine Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Nifedipine Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Nifedipine Sales Value, 2019-2030
        6.7.2 South Korea Nifedipine Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Nifedipine Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Nifedipine Sales Value, 2019-2030
        6.8.2 Southeast Asia Nifedipine Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Nifedipine Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Nifedipine Sales Value, 2019-2030
        6.9.2 India Nifedipine Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Nifedipine Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Company Information
        7.1.2 Bayer Introduction and Business Overview
        7.1.3 Bayer Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Bayer Nifedipine Product Offerings
        7.1.5 Bayer Recent Development
    7.2 Actavis
        7.2.1 Actavis Company Information
        7.2.2 Actavis Introduction and Business Overview
        7.2.3 Actavis Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Actavis Nifedipine Product Offerings
        7.2.5 Actavis Recent Development
    7.3 Teva
        7.3.1 Teva Company Information
        7.3.2 Teva Introduction and Business Overview
        7.3.3 Teva Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Teva Nifedipine Product Offerings
        7.3.5 Teva Recent Development
    7.4 Pfizer
        7.4.1 Pfizer Company Information
        7.4.2 Pfizer Introduction and Business Overview
        7.4.3 Pfizer Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Pfizer Nifedipine Product Offerings
        7.4.5 Pfizer Recent Development
    7.5 Shyndec
        7.5.1 Shyndec Company Information
        7.5.2 Shyndec Introduction and Business Overview
        7.5.3 Shyndec Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Shyndec Nifedipine Product Offerings
        7.5.5 Shyndec Recent Development
    7.6 Honglin Pharmaceutical
        7.6.1 Honglin Pharmaceutical Company Information
        7.6.2 Honglin Pharmaceutical Introduction and Business Overview
        7.6.3 Honglin Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Honglin Pharmaceutical Nifedipine Product Offerings
        7.6.5 Honglin Pharmaceutical Recent Development
    7.7 Huanghai
        7.7.1 Huanghai Company Information
        7.7.2 Huanghai Introduction and Business Overview
        7.7.3 Huanghai Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Huanghai Nifedipine Product Offerings
        7.7.5 Huanghai Recent Development
    7.8 Yabao
        7.8.1 Yabao Company Information
        7.8.2 Yabao Introduction and Business Overview
        7.8.3 Yabao Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Yabao Nifedipine Product Offerings
        7.8.5 Yabao Recent Development
    7.9 Lifeon Pharmaceutical
        7.9.1 Lifeon Pharmaceutical Company Information
        7.9.2 Lifeon Pharmaceutical Introduction and Business Overview
        7.9.3 Lifeon Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Lifeon Pharmaceutical Nifedipine Product Offerings
        7.9.5 Lifeon Pharmaceutical Recent Development
    7.10 EASEHEAL Pharmaceutical
        7.10.1 EASEHEAL Pharmaceutical Company Information
        7.10.2 EASEHEAL Pharmaceutical Introduction and Business Overview
        7.10.3 EASEHEAL Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 EASEHEAL Pharmaceutical Nifedipine Product Offerings
        7.10.5 EASEHEAL Pharmaceutical Recent Development
    7.11 ApicHope
        7.11.1 ApicHope Company Information
        7.11.2 ApicHope Introduction and Business Overview
        7.11.3 ApicHope Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 ApicHope Nifedipine Product Offerings
        7.11.5 ApicHope Recent Development
    7.12 Simcere
        7.12.1 Simcere Company Information
        7.12.2 Simcere Introduction and Business Overview
        7.12.3 Simcere Nifedipine Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Simcere Nifedipine Product Offerings
        7.12.5 Simcere Recent Development

 8 Industry Chain Analysis
    8.1 Nifedipine Industrial Chain
    8.2 Nifedipine Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Nifedipine Sales Model
        8.5.2 Sales Channel
        8.5.3 Nifedipine Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Nifedipine Market Trends
    Table 2. Nifedipine Market Drivers & Opportunity
    Table 3. Nifedipine Market Challenges
    Table 4. Nifedipine Market Restraints
    Table 5. Global Nifedipine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Nifedipine Revenue Market Share by Company (2019-2024)
    Table 7. Global Nifedipine Sales Volume by Company (2019-2024) & (MT)
    Table 8. Global Nifedipine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Nifedipine Price by Company (2019-2024) & (USD/Kg)
    Table 10. Key Manufacturers Nifedipine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Nifedipine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Nifedipine
    Table 13. Global Nifedipine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Nifedipine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Nifedipine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Nifedipine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Nifedipine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Nifedipine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Nifedipine Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)
    Table 22. Global Nifedipine Sales Volume by Type (2019-2024) & (MT)
    Table 23. Global Nifedipine Sales Volume by Type (2025-2030) & (MT)
    Table 24. Global Nifedipine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Nifedipine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Nifedipine Price by Type (2019-2024) & (USD/Kg)
    Table 27. Global Nifedipine Price by Type (2025-2030) & (USD/Kg)
    Table 28. Global Nifedipine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Nifedipine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Nifedipine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Nifedipine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Nifedipine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Nifedipine Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)
    Table 34. Global Nifedipine Sales Volume by Application (2019-2024) & (MT)
    Table 35. Global Nifedipine Sales Volume by Application (2025-2030) & (MT)
    Table 36. Global Nifedipine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Nifedipine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Nifedipine Price by Application (2019-2024) & (USD/Kg)
    Table 39. Global Nifedipine Price by Application (2025-2030) & (USD/Kg)
    Table 40. Global Nifedipine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Nifedipine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Nifedipine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Nifedipine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Nifedipine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Nifedipine Sales Volume by Region (MT): 2019 VS 2023 VS 2030
    Table 46. Global Nifedipine Sales Volume by Region (2019-2024) & (MT)
    Table 47. Global Nifedipine Sales Volume by Region (2025-2030) & (MT)
    Table 48. Global Nifedipine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Nifedipine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Nifedipine Average Price by Region (2019-2024) & (USD/Kg)
    Table 51. Global Nifedipine Average Price by Region (2025-2030) & (USD/Kg)
    Table 52. Key Countries/Regions Nifedipine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Nifedipine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Nifedipine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Nifedipine Sales Volume, (2019-2024) & (MT)
    Table 56. Key Countries/Regions Nifedipine Sales Volume, (2025-2030) & (MT)
    Table 57. Bayer Company Information
    Table 58. Bayer Introduction and Business Overview
    Table 59. Bayer Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 60. Bayer Nifedipine Product Offerings
    Table 61. Bayer Recent Development
    Table 62. Actavis Company Information
    Table 63. Actavis Introduction and Business Overview
    Table 64. Actavis Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 65. Actavis Nifedipine Product Offerings
    Table 66. Actavis Recent Development
    Table 67. Teva Company Information
    Table 68. Teva Introduction and Business Overview
    Table 69. Teva Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 70. Teva Nifedipine Product Offerings
    Table 71. Teva Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 75. Pfizer Nifedipine Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Shyndec Company Information
    Table 78. Shyndec Introduction and Business Overview
    Table 79. Shyndec Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 80. Shyndec Nifedipine Product Offerings
    Table 81. Shyndec Recent Development
    Table 82. Honglin Pharmaceutical Company Information
    Table 83. Honglin Pharmaceutical Introduction and Business Overview
    Table 84. Honglin Pharmaceutical Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 85. Honglin Pharmaceutical Nifedipine Product Offerings
    Table 86. Honglin Pharmaceutical Recent Development
    Table 87. Huanghai Company Information
    Table 88. Huanghai Introduction and Business Overview
    Table 89. Huanghai Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 90. Huanghai Nifedipine Product Offerings
    Table 91. Huanghai Recent Development
    Table 92. Yabao Company Information
    Table 93. Yabao Introduction and Business Overview
    Table 94. Yabao Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 95. Yabao Nifedipine Product Offerings
    Table 96. Yabao Recent Development
    Table 97. Lifeon Pharmaceutical Company Information
    Table 98. Lifeon Pharmaceutical Introduction and Business Overview
    Table 99. Lifeon Pharmaceutical Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 100. Lifeon Pharmaceutical Nifedipine Product Offerings
    Table 101. Lifeon Pharmaceutical Recent Development
    Table 102. EASEHEAL Pharmaceutical Company Information
    Table 103. EASEHEAL Pharmaceutical Introduction and Business Overview
    Table 104. EASEHEAL Pharmaceutical Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 105. EASEHEAL Pharmaceutical Nifedipine Product Offerings
    Table 106. EASEHEAL Pharmaceutical Recent Development
    Table 107. ApicHope Company Information
    Table 108. ApicHope Introduction and Business Overview
    Table 109. ApicHope Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 110. ApicHope Nifedipine Product Offerings
    Table 111. ApicHope Recent Development
    Table 112. Simcere Company Information
    Table 113. Simcere Introduction and Business Overview
    Table 114. Simcere Nifedipine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 115. Simcere Nifedipine Product Offerings
    Table 116. Simcere Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Nifedipine Downstream Customers
    Table 120. Nifedipine Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nifedipine Product Picture
    Figure 2. Global Nifedipine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Nifedipine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Nifedipine Sales Volume (2019-2030) & (MT)
    Figure 5. Global Nifedipine Sales Price (2019-2030) & (USD/Kg)
    Figure 6. Nifedipine Report Years Considered
    Figure 7. Global Nifedipine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Nifedipine Players Sales Volume Ranking (2023) & (MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nifedipine Revenue in 2023
    Figure 10. Nifedipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Nifedipine Controlled Release Tablets Picture
    Figure 12. Nifedipine Extended Action Tablets Picture
    Figure 13. Global Nifedipine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Nifedipine Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Nifedipine Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)
    Figure 16. Global Nifedipine Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Nifedipine Price by Type (2019-2030) & (USD/Kg)
    Figure 18. Product Picture of Hypertension
    Figure 19. Product Picture of Heart Disease
    Figure 20. Product Picture of Other
    Figure 21. Global Nifedipine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Nifedipine Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Nifedipine Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)
    Figure 24. Global Nifedipine Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Nifedipine Price by Application (2019-2030) & (USD/Kg)
    Figure 26. North America Nifedipine Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Nifedipine Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Nifedipine Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Nifedipine Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Nifedipine Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Nifedipine Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Nifedipine Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Nifedipine Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Nifedipine Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Nifedipine Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Nifedipine Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Nifedipine Sales Volume (%), (2019-2030)
    Figure 38. United States Nifedipine Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Nifedipine Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Nifedipine Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Nifedipine Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Nifedipine Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Nifedipine Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Nifedipine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Nifedipine Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Nifedipine Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Nifedipine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Nifedipine Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Nifedipine Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Nifedipine Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Nifedipine Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Nifedipine Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Nifedipine Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Nifedipine Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Nifedipine Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Nifedipine Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Nifedipine Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Nifedipine Sales Value by Application (%), 2023 VS 2030
    Figure 59. Nifedipine Industrial Chain
    Figure 60. Nifedipine Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. 
The global market for Nifedipine was estimated to be worth US$ 1010.8 million in 2023 and is forecast to a readjusted size of US$ 1726.7 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 132 Pages

Report ld: 2333662

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00